Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer undergoing checkpoint inhibitor therapy.
暂无分享,去创建一个
J. von Hardenberg | R. Stoehr | H. Taubert | B. Wullich | R. Wirtz | A. Santiago-Walker | M. Eckstein | K. Tully | D. Sikic | P. Erben | C. Bolenz | J. Breyer | F. Roghmann | M. Kriegmair | M. Burger | S. Porubský | H. Jütte | V. Weyerer | F. Zengerling | A. Hartmann | J. Jarczyk